Compare Orchid Pharma with GUFIC BIOSCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs GUFIC BIOSCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA GUFIC BIOSCIENCE ORCHID PHARMA/
GUFIC BIOSCIENCE
 
P/E (TTM) x -17.1 23.2 - View Chart
P/BV x 2.5 10.8 23.3% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 ORCHID PHARMA   GUFIC BIOSCIENCE
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-21
GUFIC BIOSCIENCE
Mar-21
ORCHID PHARMA/
GUFIC BIOSCIENCE
5-Yr Chart
Click to enlarge
High Rs2,465137 1,794.1%   
Low Rs1845 40.2%   
Sales per share (Unadj.) Rs110.350.3 219.2%  
Earnings per share (Unadj.) Rs-28.54.6 -625.6%  
Cash flow per share (Unadj.) Rs-1.96.2 -29.9%  
Dividends per share (Unadj.) Rs00.10 0.0%  
Avg Dividend yield %00.1 0.0%  
Book value per share (Unadj.) Rs159.917.9 894.0%  
Shares outstanding (eoy) m40.8296.94 42.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x11.31.8 621.8%   
Avg P/E ratio x-43.520.0 -217.8%  
P/CF ratio (eoy) x-665.614.6 -4,562.7%  
Price / Book Value ratio x7.85.1 152.4%  
Dividend payout %02.2 0.0%   
Avg Mkt Cap Rs m50,6778,832 573.8%   
No. of employees `000NANA-   
Total wages/salary Rs m671662 101.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,5014,877 92.3%  
Other income Rs m15237 407.9%   
Total revenues Rs m4,6534,914 94.7%   
Gross profit Rs m294839 35.0%  
Depreciation Rs m1,089163 667.9%   
Interest Rs m522136 382.9%   
Profit before tax Rs m-1,165577 -201.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0135 0.0%   
Profit after tax Rs m-1,165442 -263.5%  
Gross profit margin %6.517.2 37.9%  
Effective tax rate %023.4 0.0%   
Net profit margin %-25.99.1 -285.5%  
BALANCE SHEET DATA
Current assets Rs m5,4993,168 173.6%   
Current liabilities Rs m1,4212,198 64.6%   
Net working cap to sales %90.619.9 455.9%  
Current ratio x3.91.4 268.6%  
Inventory Days Days2014 146.9%  
Debtors Days Days1,101932 118.1%  
Net fixed assets Rs m6,8741,315 522.8%   
Share capital Rs m40897 421.0%   
"Free" reserves Rs m6,1211,637 373.8%   
Net worth Rs m6,5291,734 376.5%   
Long term debt Rs m4,275354 1,206.7%   
Total assets Rs m12,3734,482 276.0%  
Interest coverage x-1.25.2 -23.5%   
Debt to equity ratio x0.70.2 320.6%  
Sales to assets ratio x0.41.1 33.4%   
Return on assets %-5.212.9 -40.3%  
Return on equity %-17.825.5 -70.0%  
Return on capital %-6.034.2 -17.4%  
Exports to sales %88.111.5 765.8%   
Imports to sales %37.322.5 165.6%   
Exports (fob) Rs m3,966561 706.6%   
Imports (cif) Rs m1,6771,097 152.8%   
Fx inflow Rs m3,966561 706.6%   
Fx outflow Rs m1,7291,097 157.6%   
Net fx Rs m2,237-536 -417.3%   
CASH FLOW
From Operations Rs m236891 26.5%  
From Investments Rs m672-85 -790.0%  
From Financial Activity Rs m-1,650-786 209.9%  
Net Cashflow Rs m-74219 -3,824.6%  

Share Holding

Indian Promoters % 90.0 75.5 119.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.2 3.7 141.9%  
FIIs % 1.8 1.5 117.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.0 24.5 40.8%  
Shareholders   34,798 35,135 99.0%  
Pledged promoter(s) holding % 32.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   SHREE GANESH REMEDIES   PHAARMASIA  JUBILANT PHARMOVA   IND SWIFT LA  PARNAX LAB  



Today's Market

Sensex Jumps 500 Points, Nifty Above 17,100; Metal & Automobile Stocks Rally(10:30 am)

Asian stock markets swung between positive and negative territory as investors remained cautious about a new virus strain and US monetary policy moves over inflation.

Related Views on News

GUFIC BIOSCIENCE 2020-21 Annual Report Analysis (Annual Result Update)

Nov 1, 2021 | Updated on Nov 1, 2021

Here's an analysis of the annual report of GUFIC BIOSCIENCE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GUFIC BIOSCIENCE. Also includes updates on the valuation of GUFIC BIOSCIENCE.

Why Did Orchid Pharma Shares Plunge 10% Today? (Views On News)

Jun 25, 2021

Orchid Pharma shares plunge 10% as company fixes OFS price at 72% discount.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Dec 1, 2021 03:36 PM

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ORCHID PHARMA - SANJIVANI PA COMPARISON

COMPARE ORCHID PHARMA WITH

MARKET STATS